Adaptive Immunity
Adaptive Immunity(适应性免疫)
Adaptive Immunity 相关产品(209)
- GC43288Cochlioquinone ACAS: 32450-25-2纯度: >99.00%
An inhibitor of diacylglycerol kinase and diacylglycerol acyltransferase
- GC43350Cyclosporin BCAS: 63775-95-1纯度: >98.00%
A fungal metabolite with diverse biological activities
- GC43721Galactosylcerebrosides (hydroxy)CAS: 37211-11-3纯度: >98.00%
A mixture of isolated bovine hydroxy galactosylceramides
- GC43742Gemcitabine-13C,15N2 (hydrochloride)CAS: 2757566-59-7纯度: >98.00%
An internal standard for the quantification of gemcitabine
- GC43804Halofuginone (hydrochloride)CAS: 1217623-74-9纯度: >95.00%
An inhibitor of TGF-β signaling and T H 17 differentiation
- GC44050Leucinostatin ACAS: 76600-38-9纯度: >95.00%
A fungal metabolite with diverse biological activities
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC43007 | C12 Galactosylceramide (d18:1/12:0) | 41613-14-3 | >98.00% | |
A bioactive sphingolipid | ||||
| GC43032 | C16 Globotriaosylceramide (d18:1/16:0) | 137896-85-6 | >98.00% | |
A sphingolipid | ||||
| GC43049 | C18 Globotriaosylceramide (d18:1/18:0) | 69283-33-6 | >98.00% | |
A sphingolipid | ||||
| GC43084 | C4 Ceramide (d18:1/4:0) | 74713-58-9 | >95.00% | |
A bioactive sphingolipid | ||||
| GC43181 | CAY10597 | 916046-55-4 | >98.00% | |
A potent CRTH2/DP 2 receptor antagonist | ||||
| GC43216 | CCR4 Antagonist (hydrochloride) | 1784252-84-1 | >98.00% | |
A CCR4 antagonist | ||||
| GC43239 | Chk2 Inhibitor | 724708-21-8 | >95.00% | |
A Chk2 inhibitor | ||||
| GC43288 | Cochlioquinone A | 32450-25-2 | >99.00% | |
An inhibitor of diacylglycerol kinase and diacylglycerol acyltransferase | ||||
| GC43307 | Concanamycin B | 81552-33-2 | >95.00% | |
A potent and selective inhibitor of V-ATPases | ||||
| GC43340 | Cyclic di-IMP (sodium salt) | - | >95.00% | |
A synthetic second messenger | ||||
| GC43350 | Cyclosporin B | 63775-95-1 | >98.00% | |
A fungal metabolite with diverse biological activities | ||||
| GC43467 | Dimethyldioctadecylammonium (bromide) | 3700-67-2 | >95.00% | |
A cationic amphipathic lipid | ||||
| GC43659 | Feglymycin | 209335-49-9 | >95.00% | |
A peptide with antibacterial and antiviral activities | ||||
| GC43701 | FTY720 phenoxy-biotin | - | >95.00% | |
Biotin-tagged FTY720 analog | ||||
| GC43721 | Galactosylcerebrosides (hydroxy) | 37211-11-3 | >98.00% | |
A mixture of isolated bovine hydroxy galactosylceramides | ||||
| GC43722 | Galactosylcerebrosides (non-hydroxy) | 536-13-0 | >98.00% | |
A sphingolipid | ||||
| GC43730 | Ganglioside GM1 Asialo Mixture | 71012-19-6 | >98.00% | |
A sphingolipid | ||||
| GC43742 | Gemcitabine-13C,15N2 (hydrochloride) | 2757566-59-7 | >98.00% | |
An internal standard for the quantification of gemcitabine | ||||
| GC43804 | Halofuginone (hydrochloride) | 1217623-74-9 | >95.00% | |
An inhibitor of TGF-β signaling and T H 17 differentiation | ||||
| GC43807 | HDMAPP (ammonium salt) | 443892-56-6 | >90.00% | |
A phosphoantigen for Vγ9Vδ2 T cells | ||||
| GC43879 | Hydroxy Ebastine | 210686-41-2 | >87.00% | |
An ebastine metabolite | ||||
| GC43928 | JJH260 | 1831135-30-8 | >90.00% | |
An inhibitor of FAHFA hydrolases | ||||
| GC44050 | Leucinostatin A | 76600-38-9 | >95.00% | |
A fungal metabolite with diverse biological activities | ||||
| GC44078 | LL-37 amide (trifluoroacetate salt) | - | >95.00% | |
An antimicrobial peptide | ||||